{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:14:19Z","timestamp":1773083659353,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1989,12]]},"DOI":"10.1007\/bf02263482","type":"journal-article","created":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T17:54:19Z","timestamp":1134064459000},"page":"279-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra"],"prefix":"10.1007","volume":"1","author":[{"given":"B.","family":"Fornstedt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1989,12,1]]},"reference":[{"key":"BF02263482_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2340\/00015555542122","volume":"54","author":"G Agrup","year":"1974","unstructured":"Agrup G, Falck B, Jacobsson S, Rorsman H, Rosengren AM, Rosengren E (1974) 5-S-Cysteinyldopa in melanomas of caucasians. Acta Derm Venereol (Stockholm) 54: 21\u201323","journal-title":"Acta Derm Venereol (Stockholm)"},{"key":"BF02263482_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2340\/00015555635961","volume":"63","author":"G Agrup","year":"1983","unstructured":"Agrup G, Edholm L-E, Rorsman H, Rosengren E (1983) Diastereomers of 5-S-cysteinyl-DOPA. Acta Derm Venereol (Stockholm) 63: 59\u201361","journal-title":"Acta Derm Venereol (Stockholm)"},{"key":"BF02263482_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","volume":"32","author":"LM Ambani","year":"1975","unstructured":"Ambani LM, Melvin H, van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson's disease. Arch Neurol 32: 114\u2013118","journal-title":"Arch Neurol"},{"key":"BF02263482_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0022-3565(25)26438-2","volume":"138","author":"AH Anton","year":"1962","unstructured":"Anton AH, Sayre DF (1962) A study of the factors affecting the aluminium oxidetrihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360\u2013375","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl","key":"BF02263482_CR5","first-page":"89","volume":"19","author":"G Cohen","year":"1983","unstructured":"Cohen G (1983) The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J Neural Transm 19 [Suppl]: 89\u2013103","journal-title":"J Neural Transm"},{"key":"BF02263482_CR6","series-title":"Communications from the Department of Anatomy","volume-title":"5-S-Cysteinyldopa in the urine of melanoma patients","author":"I Dahlqvist","year":"1972","unstructured":"Dahlqvist I, Falck B, Jacobsson S, Rorsman H, Rosengren AM, Rosengren E (1972) 5-S-Cysteinyldopa in the urine of melanoma patients. Communications from the Department of Anatomy, University of Lund, Sweden, No. 7"},{"key":"BF02263482_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1471-4159.1978.tb07814.x","volume":"30","author":"KC Das","year":"1978","unstructured":"Das KC, Abramson MB, Katzman R (1978) Neuronal pigments: spectroscopic characterization of human brain melanin. J Neurochem 30: 601\u2013605","journal-title":"J Neurochem"},{"key":"BF02263482_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(86)92471-2","volume":"ii","author":"DT Dexter","year":"1986","unstructured":"Dexter DT, Carter C, Agid F, Agid Y, Lees AJ, Jenner P, Mardsen CD (1986) Lipid peroxidation as cause of nigral cell death in Parkinson's disease. Lancet ii: 639\u2013640","journal-title":"Lancet"},{"key":"BF02263482_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","volume":"ii","author":"DT Dexter","year":"1987","unstructured":"Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Mardsen CD (1987) Increased nigral iron content in post mortem parkinsonian brain. Lancet ii: 1219\u20131220","journal-title":"Lancet"},{"key":"BF02263482_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF01249607","volume":"52","author":"C Fehling","year":"1981","unstructured":"Fehling C, Hansson C, Poulsen J, Rorsman H, Rosengren E (1981) 5-S-Cysteinyldopa in ganglion stellatum. J Neural Transm 52: 251\u2013257","journal-title":"J Neural Transm"},{"key":"BF02263482_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0028-3908(86)90242-X","volume":"25","author":"B Fornstedt","year":"1986","unstructured":"Fornstedt B, Rosengren E, Carlsson A (1986) Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 25: 451\u2013454","journal-title":"Neuropharmacology"},{"key":"BF02263482_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01578755","volume":"76","author":"B Fornstedt","year":"1989","unstructured":"Fornstedt B, Carlsson A (1989) A marked rise in 5-S-cysteinyl-dopamine levels in guineapig striatum following reserpine treatment. J Neural Transm 76: 155\u2013161","journal-title":"J Neural Transm"},{"key":"BF02263482_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14: 633\u2013643","journal-title":"Mol Pharmacol"},{"key":"BF02263482_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG, Tiffany SM, Bell WRJr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C 1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644\u2013653","journal-title":"Mol Pharmacol"},{"key":"BF02263482_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/BF01978591","volume":"36","author":"S Ito","year":"1980","unstructured":"Ito S, Novellino E, Chiocarra F, Misuraca O, Prota G (1980) Co-polymerization of dopa and cysteinyldopa in melanogenesis in vitro. Experientia 36: 822\u2013823","journal-title":"Experientia"},{"key":"BF02263482_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0378-4347(00)83700-7","volume":"375","author":"S Ito","year":"1986","unstructured":"Ito S, Fujita K, Yoshioka M, Sienko D, Nagatsu T (1986) Identification of 5-S- and 2-S-cysteinyldopamine and 5-C-glutathionyldopamine formed from dopamine by highperformance liquid chromatography with electrochemical detection. J Chromatogr 375: 134\u2013140","journal-title":"J Chromatogr"},{"key":"BF02263482_CR17","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318: 876\u2013880","journal-title":"N Engl J Med"},{"key":"BF02263482_CR18","volume-title":"Analyses of messy data","author":"GA Milliken","year":"1984","unstructured":"Milliken GA, Johnson DE (1984) Analyses of messy data. Lifetime Learning Publications, Belmont, California, U.S.A."},{"key":"BF02263482_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0165-1218(83)90181-7","volume":"124","author":"P Mold\u00e9us","year":"1983","unstructured":"Mold\u00e9us P, Nordenskj\u00f6ld M, Bolcsfoldi G, Eiche A, Haglund U, Lambert B (1983) Genetic toxicity of dopamine. Mutat Res 124: 9\u201324","journal-title":"Mutat Res"},{"key":"BF02263482_CR20","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/BF02286912","volume":"27","author":"L Nordgren","year":"1971","unstructured":"Nordgren L, Rorsman H, Rosengren A-M, Rosengren E (1971) Dopa and dopamine in the pigment of substantia nigra. Experientia 27: 1178\u20131179","journal-title":"Experientia"},{"key":"BF02263482_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","volume":"33","author":"TL Perry","year":"1982","unstructured":"Perry TL, Godin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33: 305\u2013310","journal-title":"Neurosci Lett"},{"key":"BF02263482_CR22","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/BF01933916","volume":"32","author":"G Prota","year":"1976","unstructured":"Prota G, Rorsman H, Rosengren AM, Rosengren E (1976) Pheaomelanic pigment from a human melanoma. Experientia 32: 970\u2013971","journal-title":"Experientia"},{"key":"BF02263482_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathion and ascorbic acid in parkinsonian brains. J Neurochem 52: 515\u2013520","journal-title":"J Neurochem"},{"key":"BF02263482_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1471-4159.1975.tb03887.x","volume":"24","author":"AD Rodgers","year":"1975","unstructured":"Rodgers AD, Curzon G (1975) Melanin formation by human brain in vitro. J Neurochem 24: 1123\u20131129","journal-title":"J Neurochem"},{"key":"BF02263482_CR25","first-page":"243","volume-title":"Pigment cell, vol 4","author":"H Rorsman","year":"1979","unstructured":"Rorsman H, Agrup G, Hansson C, Rosengren AM, Rosengren E (1979) Detection of pheomelanins. In: Klaus SN (ed) Pigment cell, vol 4. Karger, Basel, pp 243\u2013253"},{"key":"BF02263482_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF01252029","volume":"63","author":"E Rosengren","year":"1985","unstructured":"Rosengren E, Linder-Eliasson E, Carlsson A (1985) Detection of 5-S-cysteinyldopamine in human brain. J Neural Transm 63: 247\u2013253","journal-title":"J Neural Transm"},{"key":"BF02263482_CR27","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/0006-291X(75)90514-8","volume":"66","author":"M Scheulen","year":"1975","unstructured":"Scheulen M, Wollenberg P, Bolt HM, Kappus H, Remmer H (1975) Irreversible binding of dopa and dopamine metabolites to protein by rat liver microsomes. Biochem Biophys Res Commun 66: 1396\u20131400","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02263482_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1126\/science.6283638","volume":"217","author":"R Sealy","year":"1982","unstructured":"Sealy R, Hyde J, Felix C, Menon IA, Prota G (1982) Eumelanins and pheomelanins: characterisation by electron spin resonance. Science 217: 545\u2013547","journal-title":"Science"},{"key":"BF02263482_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2340\/00015555541920","volume":"54","author":"CL Vogel","year":"1974","unstructured":"Vogel CL, Dhru Dh, Rorsman H, Rosengren AM, Rosengren E (1974) Dopa and 5-S-cysteinyldopa in malignant melanoma in Ugandan Africans. Acta Derm Venereol (Stockholm) 54: 19\u201321","journal-title":"Acta Derm Venereol (Stockholm)"},{"key":"BF02263482_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1523-1747.ep12546959.1","volume":"71","author":"MM Wick","year":"1978","unstructured":"Wick MM (1978) Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Derm 71: 163\u2013164","journal-title":"J Invest Derm"},{"key":"BF02263482_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.877570","volume":"197","author":"MM Wick","year":"1977","unstructured":"Wick MM, Byers L, Frei E III (1977) L-Dopa: selective toxicity for melanoma cells in vitro. Science 197: 468\u2013469","journal-title":"Science"},{"key":"BF02263482_CR32","first-page":"1414","volume":"40","author":"MM Wick","year":"1980","unstructured":"Wick MM (1980) Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res 40: 1414\u20131418","journal-title":"Cancer Res"},{"key":"BF02263482_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0006-8993(74)90247-9","volume":"65","author":"F-A Wiesel","year":"1974","unstructured":"Wiesel F-A, Sedvall G (1974) Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography. Brain Res 65: 547\u2013550","journal-title":"Brain Res"},{"key":"BF02263482_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1471-4159.1967.tb10304.x","volume":"14","author":"MH Van Woert","year":"1967","unstructured":"Van Woert MH, Prasad KN, Borg DC (1967) Spectroscopic studies of substantia nigra pigment in human subjects. J Neurochem 14: 707\u2013716","journal-title":"J Neurochem"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02263482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02263482\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02263482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02263482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:52:13Z","timestamp":1750819933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02263482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["BF02263482"],"URL":"https:\/\/doi.org\/10.1007\/bf02263482","relation":{},"ISSN":["0936-3076"],"issn-type":[{"value":"0936-3076","type":"print"}],"subject":[],"published":{"date-parts":[[1989,12]]},"assertion":[{"value":"2 May 1989","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 1989","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 1989","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}